Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Malabsorption Syndromes

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Malabsorption Syndromes:

Pubmed Logo
Vitamin K in parenteral nutrition.
Vitamin K (as phylloquinone and menaquinones) is an essential cofactor for...
13th November, 2009
Centre for Haemostasis and Thrombosis, St Thomas' Hospital, London, United Gastroenterology. 2009 Nov;137(5 Suppl):S105-18.
DOI Direct Link
[Hepato-biliary and pancreatic disease and osteodystrophy]
It is well known that insulin resistance affects osteodystrophy, and there...
10th November, 2009
Department of Gastroenterology and Metabolism, Nagoya City University Clin Calcium. 2009 Sep;19(9):1275-80.
DOI Direct Link
The benefit of pre- and post-challenge urine heavy metal testing: part 2.
Measuring heavy metal levels in the urine is an accepted method for...
30th October, 2009
Environmental Medicine, Southwest College of Naturopathic Medicine. Altern Med Rev. 2009 Jun;14(2):103-8.
[Prospects of malabsorption syndrome prophylaxis and therapy]
It is well known that insulin resistance affects osteodystrophy, and there...
17th October, 2009
Antibiot Khimioter. 2009;54(3-4):49-51.
A short review of malabsorption and anemia.
Anemia is a frequent finding in most diseases which cause malabsorption....
10th October, 2009
Department of Gastroenterology, Hospital Universitari Mutua Terrassa, World J Gastroenterol. 2009 Oct 7;15(37):4644-52.

View more research publications.

Press Releases About Malabsorption Syndromes:

BioPortfolio Logo
Reportlinker Adds Pulmonary Drug Delivery Technologies - A Global Market Perspective 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Pulmonary Drug Delivery Technologies - A Global Market Perspective http:/
Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 18th November, 2009 Viron Therapeutics Inc.
VT-111 significantly reduces key cardiac enzymes at multiple time points after stent placement; Data presented at American Heart Association 2009 Scientific Sessions LONDON, ON, Nov. 18 /PRNewswire/
Viron to Present Data from Phase II Trial at American Heart Association Conference 11th November, 2009 Viron Therapeutics Inc.
LONDON, ON, Nov. 11 /PRNewswire/ - Viron Therapeutics Inc., a biopharmaceutical company pioneering the development of viral protein therapeutics, announced today that the Company's research
TessArae Delivers Lower Cost Option to Genetic Testing Market 9th November, 2009 TessArae, LLC
POTOMAC FALLS, Va., Nov. 9 /PRNewswire/ -- TessAraeĀ® LLC, a global leader in resequencing microarray-based applications, announces the launch of new integrated product solutions for genetic testing
Regeneron Reports Third Quarter 2009 Financial and Operating Results 3rd November, 2009 Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y., Nov. 3 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced financial and operating results for the third quarter of 2009. The Company reported a

BioNews Results for Malabsorption Syndromes:

RSS Logo
BioPortfolio Logo
Study IDs Prognostic Gene Signature for Metastatic Melanoma
GenomeWeb:  Nov 13 2009 2:15AM Matching: syndromes
Viron to Present Data from Phase II Trial at American Heart Association Conference
Therapeutics Daily:  Nov 12 2009 1:30PM Matching: syndromes
Viron to Present Data from Phase II Trial at American Heart Association Conference
KOTA Territory News:  Nov 12 2009 11:33AM Matching: syndromes
Viron to Present Data from Phase II Trial at American Heart Association Conference
KSLA:  Nov 12 2009 6:04AM Matching: syndromes
Malnutrition Syndromes: A Conundrum vs Continuum
MDLinx:  Nov 12 2009 3:45PM Matching: syndromes
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Malabsorption Syndromes Clinical Trials:

Clinical Trials Logo
Fructose Malabsorption in Northern Norway

Malabsorption Syndromes Patents:

USPTO Logo
US Patent No.Title
7202029 Nucleic acids encoding human TANGO 195
7348140 Clinical indications for genotyping polymorphic variants of G-protein coupled receptors
7368527 HADDE71 polypeptides
7368531 Human secreted proteins
7371727 Methods and compositions for the treatment of gastrointestinal disorders

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Malabsorption Syndromes scientists - we have details of around 682 individuals working on Malabsorption Syndromes .


This page has been viewed 300 times
Recent Search Terms used to find this page: fructose malabsorption folate | fructose malabsorption nhs | celiac disease presenting as autism | fructose malabsorption enzyme 2009 patent | clinical view of malabsorption | clinical view of malabsorption | nhs direct hematinics | nhs direct-hematinics | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Malabsorption Syndromes across BioPortfolio, or for Malabsorption Syndromes Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.